Blockbuster “Sofosbuvir” Hepatitis C drug now under price control in India
National Pharmaceutical Pricing Authority (NPPA) has brought under price control revolutionary drug ‘Sofosbuvir’ prescribed for patients with Hepatitis C. Sofosbuvir cannot be... Read More
Cipla to launch generic Sovaldi in India
Cipla is launching low-cost version of Gilead Sciences’ Sovaldi in India. With a launch planned this week, Cipla will become the latest... Read More